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Cardiac myosin binding protein C (cMyBP-C) is a sarcomeric protein that
plays an essential role in the regulation of cardiac contraction. Until recently,
cMyBP C was thought to hamper cross bridge cycling trough interaction of
its N-terminus with the heads of myosin. However, the N-terminal domains
of cMyBP-C can also bind with actin and this interaction could well explain
the currently known functions of cMyBP-C. For instance, by forming a connec-
tion between the thin and the thick filament cMyBP-C could pose a load on the
sarcomere and alter its visco-elastic properties. Additionally, cMyBP-C could
alter the activation state of the thin filament by intervening with the position of
tropomyosin.
To study the physiological relevance of an interaction between cMyBP-C and
actin, we created a transgenic mouse with a point mutation (L348P) that in-
creases the binding affinity between cMyBP-C and actin in vitro. We hypoth-
esized that stronger binding between cMyBP-C and actin will cause- through
afore mentioned mechanisms, which have been demonstrated in different in vi-
tro studies- stiffer cardiomyocytes which would ultimately lead to diastolic
dysfunction in the hearts of L348P-Tg mice.
Results show that the left atria of L348P-Tg mice are significantly enlarged.
Echocardiograms in 12 week old animals demonstrated misshapen E and A
waves, making diastolic function difficult to determine. Interestingly, pulse
wave and tissue Doppler images were more defined in 24 weeks old mice.
Preliminary data show decreased early blood flow over the mitral valve
(E) and mitral valve movement (E’) in L348PTg mice, indicative of a stiffer
left ventricle. In correspondence with that, isovolumetric relaxation time was
prolonged. At neither age we observed systolic dysfunction. Additional in-
depth hemodynamic studies to characterize the mechanisms of cardiac func-
tion longitudinally in L348P-Tg mice are ongoing.
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Cardiac myosin binding protein C (cMyBP-C) is a thick filament protein that
plays an important role in modulating contraction of the heart. Mutations in
cMyBP-C are a major cause of inherited hypertrophic cardiomyopathy
(HCM). In addition to binding to myosin, cMyBP-C also interacts with
thin filaments via its N-terminal region, mainly the C1 and M-domains,
enhancing thin filament Ca2þ-sensitivity. L348P is an HCM-causing muta-
tion that occurs in a conserved sequence in the M-domain, enhancing
cMyBP-C binding to actin and thin filament Ca2þ-sensitization (Bezold et
al., JBC 2013). Our goal was to elucidate the structural basis of L348P’s
gain of function. By EM 3D reconstruction we previously showed that bind-
ing of N-terminal cMyBP-C fragments to actin causes displacement of tropo-myosin from its blocked (low Ca2þ) position to its closed (high Ca2þ)
position (Mun et al., PNAS 2014), consistent with the increase in thin
filament Ca2þ-sensitivity. Phosphorylation of the M-domain resulted in a
smaller movement of tropomyosin. Here we have investigated the impact
of the L348P mutation on tropomyosin shift. Thin filaments were decorated
with wild type C1C2 (containing the C1, C2 and M-domains) and with C1C2
having the L348P mutation. F-actin reconstructions showed additional den-
sity on actin subdomain 1 with both fragments, but the density was larger
with L348P. When thin filaments at low Ca2þ were decorated with C1C2,
tropomyosin moved from the blocked to the closed position, as found previ-
ously. In contrast, C1C2-L348P showed a significantly larger tropomyosin
shift, to approximately the open position, consistent with L348P’s greater
Ca2þ-sensitization of motility and enhanced Ca2þ sensitivity of tension in
cardiac myocytes. Preliminary studies showed a smaller shift with phosphor-
ylated than with unphosphorylated C1C2, while phosphorylated C1C2-
L348P showed a larger shift, comparable to L348P.
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Although cardiac myosin binding protein C (cMyBP-C) has a key regulatory
role in cardiac contraction, the mechanism by which changes in phosphory-
lation of cMyBP-C affect crossbridge kinetics remains unknown. cMyBP-C
mediated changes in thick filament structure, binding of cMyBP-C to the
thin filament, or both remain viable alternatives. In this study, we isolated
thick filaments from the hearts of phosphomimetic mice in which the three
phosphorylatable serine residues (Ser273, Ser282 and Ser302) in the m-
domain of cMyBP-C were replaced by either alanine or aspartic acid to
mimic the fully non-phosphorylated (CT-SA mice) or fully phosphorylated
(CT-SD mice) state of cMyBP-C, respectively. Thus, the state of phosphor-
ylation of cMyBP-C of every filament was known in this transgenic system.
We found that the thick filaments from the CT-SA mouse hearts correspond-
ing to the non-phosphorylated state of cMyBP-C had highly ordered cross-
bridge arrays, while the filaments from the CT-SD mouse hearts showed a
strong tendency towards disorder of the myosin array. These results are
consistent with our previous studies of filaments from cMyBP-C knockout
mouse hearts. The results support the hypothesis that dephosphorylation of
cMyBP-C promotes or stabilizes the relaxed quasi-helical ordering of the
myosin heads on the backbone consistent with slower crossbridge kinetics;
while filaments with phosphorylated cMyBP-C show a greater tendency to-
wards disorder of the heads consistent with increased flexibility of the
myosin heads, extension of the heads from the backbone, and increased po-
tential interaction with the actin thin filament. Work supported by NIH
grants SC1 HL096017 (RWK), AR034711 (RC), R37 HL82900 and P01
HL094291 (RLM). RC also received funding through PPG grant P01
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